Sosei Group: Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568

JPX · Apr 16 14:30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.